Track topics on Twitter Track topics that are important to you
75 Fifth Street, N.W., Suite 440
United States of America
PhaseBio Pharmaceuticals said today it won a $2.8 million Fast Track Small Business Innovation Research (SBIR) grant from the NIH toward clinical development of its lead candidate PB1046 for pulmonary...
We report the first patient experiences with the CardioMEMS device in the Erasmus MC Thorax Center in the Netherlands. In line with clinical trial evidence, the device is applicable in patients with c...
CardioMEMS is an implantable wireless hemodynamic monitoring system which can transmit the pulmonary artery pressure. This device is FDA approved to be used as a diagnostic tool to help ma...
The purpose of this study is to characterize the use of the CardioMEMS™ HF System when used in a real-world setting.
Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.
The purpose of this Post Approval Study (PAS) is to evaluate the use of the CardioMEMS HF System in patients with Class III Heart Failure in a commercial setting.
This study aims to establish the degree to which change in the ratio of ECF to TBW measured using the SOZO BIS device correlates with change in end-expiratory end-diastolic PAP measured us...
MEMS (an acronym for MicroElectroMechanical Systems) technology uses semiconductor industry techniques to create micron scale machines incorporating both mechanical and electronic components. The staf...
We have published hundreds of CardioMEMS Inc news stories on BioPortfolio along with dozens of CardioMEMS Inc Clinical Trials and PubMed Articles about CardioMEMS Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CardioMEMS Inc Companies in our database. You can also find out about relevant CardioMEMS Inc Drugs and Medications on this site too.